| Director, Channel Operations Strategy - Advanced Platforms- Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
3月 04, 2025 |
| Comptable Général(e) Expérimenté(e) H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Finance |
CTS |
Audit & Finance |
3月 04, 2025 |
| Computer-Aided Drug Design Data Science AI/ML Expert |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Data and Digital |
3月 04, 2025 |
| Facilities Engineer |
Indianapolis |
USA |
Operations |
Innovative Medicines |
Technical Operations |
3月 04, 2025 |
| Packaging Specialist |
Millburn |
USA |
Operations |
Innovative Medicines |
Technical Operations |
3月 04, 2025 |
| Exec Director TPPM - TA Head Immunology NCE |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
3月 04, 2025 |
| RLT中心业务经理 |
Wuxi (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| Senior People Partner - US |
Hyderabad (Office) |
India |
People & Organization |
CTS |
Human Resources |
3月 04, 2025 |
| Senior DEI Generalist |
Hyderabad (Office) |
India |
People & Organization |
Corporate |
Human Resources |
3月 04, 2025 |
| Head Medical Excellence and Operation |
Mumbai (Head Office) |
India |
International |
Innovative Medicines |
Research & Development |
3月 04, 2025 |
| Senior Financial Analyst, US BPA |
Hyderabad (Office) |
India |
Finance |
Innovative Medicines |
Audit & Finance |
3月 04, 2025 |
| Manager - Digital Finance Operations |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| Manager, Product Brand Comms |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
3月 04, 2025 |
| Associate, Automation Engineer |
Sasayama |
Japan |
Operations |
|
Technical Operations |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| Lead, RWE and Evidence Excellence |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Research & Development |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| W&D Category Buyer APAC |
Shanghai (Shanghai) |
China |
Operations |
Innovative Medicines |
Procurement |
3月 04, 2025 |
| 县域主任/县域主管 |
Eerduosi (Neimenggu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Lanzhou (Gansu Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Taian (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Jinhua (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Taizhou (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Zhanjiang (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Sales |
3月 04, 2025 |
| MR Intern |
Nanning (Guangxi Province) |
China |
International |
Innovative Medicines |
Others |
3月 04, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
3月 03, 2025 |
| (高级）医药代表 /（资深）产品专员 |
Xinyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
3月 03, 2025 |
| QA Batch Release Specialist |
Indianapolis |
USA |
Operations |
Innovative Medicines |
Quality |
3月 03, 2025 |
| Operater v proizvodnji farmacevtskih učinkovin (m/ž/d) |
Mengeš |
Slovenia |
Operations |
Innovative Medicines |
Technical Operations |
3月 03, 2025 |
| Drug Substance Project Manager (E2E) |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
3月 03, 2025 |
| Associate Director Business Analyst Salesforce Data Cloud |
Barcelona Gran Vía |
Spain |
Operations |
CTS |
Technology Transformation |
3月 03, 2025 |
| Laboratorijski analitik (m/ž/d) |
Mengeš |
Slovenia |
Operations |
Innovative Medicines |
Quality |
3月 03, 2025 |
| ROTKREUZ Value Demonstration & HEOR Manager (80-100%*) |
Rotkreuz (Office-Based) |
Switzerland |
International |
Innovative Medicines |
Market Access |
3月 03, 2025 |